Speaker illustration

Associate Professor Jan Beyer-Westendorf

University Hospital "Carl Gustav Carus" Dresden, Center for Vascular Medicine, Dresden (Germany)

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Oral Anticoagulation

Session: Atrial fibrillation e-posters

Thumbnail

Beyond real word evidence: learnings from databases and registers

Event: ESC CONGRESS 2019

Topic: Cardio-Oncology

Session: NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice

Thumbnail

Thrombotic events in bleeding patients treated with andexanet alfa: an ANNEXA-4 sub-study

Event: ESC CONGRESS 2019

Topic: Clinical

Session: Interventions for stroke: From prevention to acute treatment

Thumbnail

What do the data say about stroke prevention and renal impairment?

Event: ESC Congress 2018

Topic: Prevention

Session: Translating real world evidence into your clinical practice for your multi-morbid patient

Thumbnail

From study to the clinic... Does consistency of outcome matter.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: The novel oral anticoagulants (NOACS)... From clinical theory to clinical practice - The value of consistency of outcome

Thumbnail

Making sense of the data.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)

Thumbnail

Evaluating the prospective RWE registries... The rules.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)

Thumbnail

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Clinical features and management of atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk